once-weekly semaglutide in adults with alcohol use disorder versus placebo patients and comorbid obesity: a randomised, double-blind, placebo-controlled trial A new study in The

JamshedHBeylRADella MannaDLYangESRavussinEPetersonCM

A Georgia-licensed professional recommends one based on your health profile, goals and tolerance

Rather than forcing metabolic change through brute biochemical intervention, GLP-1 drugs supraphysiologically modulate endogenous signalling systems already evolved for energy regulation

A spokesman said the company was disappointed

These findings are virtually identical to the results of the STEP 1 trial for the 2.4 mg injectable semaglutide, which reported a 14.9%-16% weight reduction over a similar period

The study analyzed medical records over the course of six years and was conducted by Mass Eye and Ear, which is a Harvard teaching hospital that specializes in eye care and research